Theralase Launches Next Generation Therapeutic Laser in USA Toronto, Ontario (FSCwire) - Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and destroy cancer, announced today that it has commenced launch of its next generation therapeutic laser, the TLC-2000 Therapeutic Medical Laser System, in the United States. The United States market represents over 1.3 million practitioners with the ability to purchase...
↧